https://costunolideinhibitor.c....om/non-invasive-asse
Interestingly, accessing the International Microarray Innovations in Leukemia (MILE) research team, we detected that both EHMT1 and EHMT2 tend to be overexpressed in most. More crucial, we determined that inhibition of EHMT1/EHMT2 substantially reduced Jurkat cell viability in a dose-dependent manner. Appropriately, we noticed that inhibition of EHMT1/EHMT2 presented Jurkat cell death, which was followed by enhanced expression of P53, TP73, BAX, and MDM4. These results c
Like
Comment
Share
